Literature DB >> 20661322

Therapeutic strategies for diastolic dysfunction: a clinical perspective.

Jong-Won Ha1, Jae K Oh.   

Abstract

Diastolic dysfunction, which is increasingly viewed as being influential in precipitating heart failure and determining prognosis, is often unrecognized and has therapeutic implications distinct from those that occur with systolic dysfunction. In this review, several therapeutic modalities including pharmacologic, nonpharmacologic, and surgical approaches for primary diastolic dysfunction and heart failure will be discussed.

Entities:  

Keywords:  Diastolic dysfunction; Therapy

Year:  2009        PMID: 20661322      PMCID: PMC2889378          DOI: 10.4250/jcu.2009.17.3.86

Source DB:  PubMed          Journal:  J Cardiovasc Ultrasound        ISSN: 1975-4612


  90 in total

1.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

2.  Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase.

Authors:  U Schmidt; F del Monte; M I Miyamoto; T Matsui; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Circulation       Date:  2000-02-22       Impact factor: 29.690

3.  Optimum heart rate of large failing hearts.

Authors:  H J Levine
Journal:  Am J Cardiol       Date:  1988-03-01       Impact factor: 2.778

4.  Chronic exercise prevents characteristic age-related changes in rat cardiac contraction.

Authors:  H A Spurgeon; M F Steinbach; E G Lakatta
Journal:  Am J Physiol       Date:  1983-04

5.  Endothelin is a potent mitogen for rat vascular smooth muscle cells.

Authors:  Y Hirata; Y Takagi; Y Fukuda; F Marumo
Journal:  Atherosclerosis       Date:  1989-08       Impact factor: 5.162

6.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

7.  Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells.

Authors:  O Hernández-Perera; D Pérez-Sala; E Soria; S Lamas
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

Review 8.  Effects of calcium antagonists on left ventricular structure and function.

Authors:  S Betocchi; M Chiariello
Journal:  J Hypertens Suppl       Date:  1993-03

9.  Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure.

Authors:  P B Clarkson; N M Wheeldon; R J MacFadyen; S D Pringle; T M MacDonald
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

Review 10.  The importance of left ventricular hypertrophy in human hypertension.

Authors:  T Kahan
Journal:  J Hypertens Suppl       Date:  1998-09
View more
  8 in total

Review 1.  Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.

Authors:  Muhammad Asrar ul Haq; Chiew Wong; Vivek Mutha; Nagesh Anavekar; Kwang Lim; Peter Barlis; David L Hare
Journal:  World J Cardiol       Date:  2014-02-26

2.  The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca2+-desensitizer.

Authors:  Sienna Wong; Han-Zhong Feng; J-P Jin
Journal:  J Mol Cell Cardiol       Date:  2019-09-07       Impact factor: 5.000

3.  Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.

Authors:  Seyedvahid Khodaei; Alison Henstock; Reza Sadeghi; Stephanie Sellers; Philipp Blanke; Jonathon Leipsic; Ali Emadi; Zahra Keshavarz-Motamed
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

4.  Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.

Authors:  Kyungil Park; Tae-Ho Park
Journal:  Trials       Date:  2016-11-03       Impact factor: 2.279

5.  Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.

Authors:  Manas Kumar Behera; Surendra Nath Swain; Manoj Kumar Sahu; Gaurav Kumar Behera; Debakanta Mishra; Jimmy Narayan; Ayaskant Singh; Shobhit Agarwal; Pradeep Kumar Mallick
Journal:  Int J Hepatol       Date:  2021-12-02

6.  Color M-Mode Echocardiography for Non-Invasive Assessment of the Intraventricular Pressure in Dogs Before and After Ductus Arteriosus Occlusion: A Retrospective Study.

Authors:  Miki Hirose; Ahmed S Mandour; Seijirow Goya; Lina Hamabe; Katsuhiro Matsuura; Tomohiko Yoshida; Momoko Watanabe; Kazumi Shimada; Akiko Uemura; Ken Takahashi; Ryou Tanaka
Journal:  Front Vet Sci       Date:  2022-07-12

7.  Feature Tracking Cardiac MRI Reveals Abnormalities in Ventricular Function in Patients With Bicuspid Aortic Valve and Preserved Ejection Fraction.

Authors:  Nicholas S Burris; Ana Paula S Lima; Michael D Hope; Karen G Ordovas
Journal:  Tomography       Date:  2018-03

8.  Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.

Authors:  Soon Kyu Lee; Myeong Jun Song; Seok Hwan Kim; Hyo Jun Ahn
Journal:  Clin Mol Hepatol       Date:  2018-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.